Clinical Outcomes of Autologous Bone Marrow Aspirate Concentrate Injections for Musculoskeletal Conditions
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60612
- Midwest Orthopeadics at Rush
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Musculoskeletal Condition that is able to undergo an injection
- Patient requests the procedure and enrolls with agreement to pay for the procedure
Exclusion Criteria:
- Active Cancer
- Allergies to local anesthesia
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
BMAC Group
Intervention Group
|
BMAC will be collected in the outpatient setting with local anesthesia.
The collection site will be the Posterior Superior Iliac Spine (PSIS).
This will be visualized under ultrasound prior to collection.
Local anesthesia with 1% lidocaine will be performed prior to the harvest.
BMAC harvest will be performed using the Arthrex Angel BMAC System using the Arthrex collection protocol.
The Arthrex Angel machine will be used to separate BMAC contents for injection based on Arthrex collection protocol.
Machine settings, volume of collection and volume of output have not been standardized and will be based upon harvest and the condition treated.
These will be variables recorded for consideration of optimal settings based on the patient-reported outcomes.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
WOMAC Score
Time Frame: 5 years
|
Pain and Function Score
|
5 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 16090710-IRB01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.